SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-086255
Filing Date
2023-11-14
Accepted
2023-11-13 17:34:53
Documents
68
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0923_inmedpharma.htm   iXBRL 10-Q 574989
2 DESCRIPTION OF SECURITIES OF INMED PHARMACEUTICALS INC f10q0923ex4-13_inmedpharma.htm EX-4.13 7688
3 CERTIFICATION f10q0923ex31-1_inmedpharma.htm EX-31.1 10225
4 CERTIFICATION f10q0923ex31-2_inmedpharma.htm EX-31.2 10246
5 CERTIFICATION f10q0923ex32-1_inmedpharma.htm EX-32.1 3739
6 CERTIFICATION f10q0923ex32-2_inmedpharma.htm EX-32.2 3756
7 GRAPHIC image_001.jpg GRAPHIC 4151
  Complete submission text file 0001213900-23-086255.txt   3551356

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE inm-20230930.xsd EX-101.SCH 38698
9 XBRL CALCULATION FILE inm-20230930_cal.xml EX-101.CAL 38326
10 XBRL DEFINITION FILE inm-20230930_def.xml EX-101.DEF 177407
11 XBRL LABEL FILE inm-20230930_lab.xml EX-101.LAB 348503
12 XBRL PRESENTATION FILE inm-20230930_pre.xml EX-101.PRE 188991
62 EXTRACTED XBRL INSTANCE DOCUMENT f10q0923_inmedpharma_htm.xml XML 304795
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 231400304
SIC: 2834 Pharmaceutical Preparations